• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 440

Lactobacillus reuteri strain NCIMB 30242

Intended Use: As an ingredient in beverages and beverage bases, breakfast cereals, cheeses, dairy product analogs, fats and oils, frozen dairy desserts, grain products and pastas, milk products, processed fruits and fruit juices, and sugar substitutes at levels ranging from 3.3 X 108 to 1010 colony forming units per serving
Basis: Scientific procedures
Notifier: Micropharma Ltd.
Notifier Address: 141 avenue du President Kennedy
5th Floor, UQAM - Biological Sciences Building
Unit 5569
Montreal, Quebec, CANADA
H2C 3Y7
Date of filing: Aug 16, 2012
GRAS Notice (releasable information): GRN 440 (in PDF) (7.1 MB)
Date of closure: Feb 12, 2013
FDA's Letter: FDA has no questions